{"id":"https://openalex.org/W2990545804","doi":"https://doi.org/10.1158/1535-7163.targ-19-lb-b01","title":"Abstract LB-B01: Investigation of immuno-oncology drugs with humanized mouse models: a panel of technologies to evaluate different pharmacological approaches","display_name":"Abstract LB-B01: Investigation of immuno-oncology drugs with humanized mouse models: a panel of technologies to evaluate different pharmacological approaches","publication_year":2019,"publication_date":"2019-12-01","ids":{"openalex":"https://openalex.org/W2990545804","doi":"https://doi.org/10.1158/1535-7163.targ-19-lb-b01","mag":"2990545804"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.targ-19-lb-b01","doi":"https://doi.org/10.1158/1535-7163.targ-19-lb-b01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-19-lb-b01","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007650214","display_name":"Caroline Mignard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Mignard","raw_affiliation_strings":["Oncodesign, Dijon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncodesign, Dijon","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109280175","display_name":"Olivier Duchamp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olivier Duchamp","raw_affiliation_strings":["Oncodesign, Dijon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncodesign, Dijon","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019465563","display_name":"Josselin Caradec","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Josselin Caradec","raw_affiliation_strings":["Oncodesign, Dijon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncodesign, Dijon","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060268565","display_name":"Francis Bichat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francis Bichat","raw_affiliation_strings":["Oncodesign, Dijon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncodesign, Dijon","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064583954","display_name":"Damien France","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Damien France","raw_affiliation_strings":["Oncodesign, Dijon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncodesign, Dijon","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001533001","display_name":"Fabrice Viviani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabrice Viviani","raw_affiliation_strings":["Oncodesign, Dijon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncodesign, Dijon","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112235774","display_name":"Jean\u2010Fran\u00e7ois Mirjolet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean Fran\u00e7ois Mirjolet","raw_affiliation_strings":["Oncodesign, Dijon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncodesign, Dijon","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"12_Supplement","first_page":"LB","last_page":"B01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8062000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8062000274658203,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.16740000247955322,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.9070000052452087},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8939999938011169},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8640000224113464},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.7300000190734863},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.8960000276565552},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cancer-vaccines","display_name":"cancer vaccines","score":0.9430000185966492},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.7549999952316284},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9789999723434448},{"id":"https://openalex.org/keywords/antitumor-efficacy","display_name":"antitumor efficacy","score":0.6309999823570251},{"id":"https://openalex.org/keywords/preclinical-animal-models","display_name":"preclinical animal models","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6446524858474731},{"id":"https://openalex.org/C2776156784","wikidata":"https://www.wikidata.org/wiki/Q3491954","display_name":"Humanized mouse","level":3,"score":0.6297578811645508},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6153494715690613},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5449120998382568},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.5414154529571533},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5398854613304138},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5395850539207458},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.52969890832901},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5221909880638123},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.47708067297935486},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.41954344511032104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10110548138618469}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.targ-19-lb-b01","doi":"https://doi.org/10.1158/1535-7163.targ-19-lb-b01","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.targ-19-lb-b01","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4255262883","https://openalex.org/W4244191914","https://openalex.org/W4415898903","https://openalex.org/W7148683576","https://openalex.org/W4409690503","https://openalex.org/W3134925186","https://openalex.org/W4385665681","https://openalex.org/W4403261745","https://openalex.org/W7126345177","https://openalex.org/W2794675189"],"abstract_inverted_index":{"Abstract":[0],"Immunotherapy":[1],"is":[2],"one":[3],"of":[4,13,61,71,93,97,102,146,163,170,181,188,240,272,281,291],"the":[5,11,52,54,57,69,78,99,161,168,248,292],"most":[6],"exciting":[7],"recent":[8],"breakthroughs":[9],"in":[10,42,65,81,106,204,236,251],"field":[12],"cancer":[14,22,47,62,110],"treatment.":[15],"Different":[16],"approaches":[17,64,287],"are":[18,39],"developed":[19,117],"such":[20,138,166,205],"as":[21,139,167],"vaccines,":[23],"adoptive":[24,193],"cellular":[25],"immunotherapy":[26,63],"or":[27,38,113,133],"immune":[28,136,164,218],"checkpoint":[29],"blockade,":[30],"and":[31,56,83,154,174,186,200,213,217,223,243,299],"a":[32,279],"number":[33],"have":[34],"been":[35],"regulatory":[36],"approved":[37],"currently":[40],"investigated":[41],"clinic.":[43],"Effective":[44],"immunity":[45],"against":[46],"involves":[48],"complex":[49],"interaction":[50],"between":[51],"tumor,":[53],"host":[55],"environment.":[58],"The":[59],"assessment":[60],"preclinical":[66],"settings":[67],"requires":[68],"use":[70],"appropriate":[72],"animal":[73],"models":[74,230],"that":[75,84],"sufficiently":[76],"reflect":[77],"physiological":[79],"situation":[80],"humans":[82],"must":[85],"be":[86],"chosen":[87],"carefully":[88],"to":[89,233,246,283],"address":[90],"specific":[91,134],"mechanisms":[92],"action.":[94],"In":[95],"light":[96],"evaluating":[98],"therapeutic":[100,183],"potential":[101],"different":[103,122,228,285],"immunomodulatory":[104,202,241],"agents":[105,203,242],"mice":[107],"xenografted":[108],"with":[109,275],"cell":[111,194],"lines":[112],"patient-derived":[114],"xenografts,":[115],"we":[116],"multiple":[118],"humanization":[119],"strategies":[120],"on":[121,215,296],"immuno-deficient":[123],"mouse":[124,207,277],"strains.":[125],"Either":[126],"human":[127,135],"PBMCs,":[128],"Hematopoietic":[129],"Stem":[130],"Cells":[131,141],"(HSCs),":[132],"cells":[137,148,156,173,219],"Dendritic":[140],"(DCs),":[142],"T":[143,147,152,172],"cells,":[144],"subset":[145],"(e.g.":[149],"gamma9":[150],"delta2":[151],"cells)":[153],"NK":[155],"were":[157],"used,":[158],"but":[159],"also":[160],"combinations":[162],"subpopulations":[165],"co-transfer":[169],"autologous":[171],"DCs.":[175],"We":[176],"will":[177],"highlight":[178],"some":[179],"results":[180],"our":[182],"efficacy":[184,239],"investigation":[185],"evaluation":[187],"novel":[189],"immuno-oncology":[190,273],"therapies":[191],"eg.":[192],"therapy,":[195],"bispecific":[196],"T-cell":[197],"engager":[198],"antibody,":[199],"vaccine":[201],"humanized":[206,229,276],"models,":[208],"assessing":[209],"survival,":[210],"tumor":[211],"growth":[212],"effects":[214],"tumors":[216],"by":[220],"flow":[221],"cytometry":[222],"immunohistochemistry":[224],"analyses.":[225],"All":[226],"these":[227],"can":[231],"permit":[232],"evidence":[234],"significant":[235],"vivo":[237],"antitumor":[238],"might":[244],"help":[245],"increase":[247],"success":[249],"rate":[250],"clinical":[252],"trials.":[253],"Citation":[254],"Format:":[255],"Caroline":[256],"Mignard,":[257],"Olivier":[258],"Duchamp,":[259],"Josselin":[260],"Caradec,":[261],"Francis":[262],"Bichat,":[263],"Damien":[264],"France,":[265],"Fabrice":[266],"Viviani,":[267],"Jean":[268],"Fran\u00e7ois":[269],"Mirjolet.":[270],"Investigation":[271],"drugs":[274],"models:":[278],"panel":[280],"technologies":[282],"evaluate":[284],"pharmacological":[286],"[abstract].":[288],"In:":[289],"Proceedings":[290],"AACR-NCI-EORTC":[293],"International":[294],"Conference":[295],"Molecular":[297],"Targets":[298],"Cancer":[300,311],"Therapeutics;":[301],"2019":[302],"Oct":[303],"26-30;":[304],"Boston,":[305],"MA.":[306],"Philadelphia":[307],"(PA):":[308],"AACR;":[309],"Mol":[310],"Ther":[312],"2019;18(12":[313],"Suppl):Abstract":[314],"nr":[315],"LB-B01.":[316],"doi:10.1158/1535-7163.TARG-19-LB-B01":[317]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2019-12-05T00:00:00"}